Vivimed Labs is currently trading at Rs. 325.85, up by 8.15 points or 2.57% from its previous closing of Rs. 317.70 on the BSE.
The scrip opened at Rs. 320.00 and has touched a high and low of Rs. 327.50 and Rs. 320.00 respectively. So far 13414 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 444.00 on 18-Apr-2012 and a 52 week low of Rs. 310.00 on 14-Feb-2013.
Last one week high and low of the scrip stood at Rs. 334.00 and Rs. 310.00 respectively. The current market cap of the company is Rs. 454.46 crore.
The promoters holding in the company stood at 45.15% while Institutions and Non-Institutions held 3.57% and 51.28% respectively.
Vivimed Labs has proposed to acquire Finoso Pharma for a total consideration of Rs 15 crore comprising cash, stock and deferred payment. Post acquisition, Finoso will become Vivimed’s research and development (R&D) unit to support innovators, generics and licensing efforts.
Finoso Pharma is a pharmaceutical development services company focused on formulations product development efforts for multiple markets and develops globally accepted dossiers.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1665.25 |
| Dr. Reddys Lab | 1220.75 |
| Cipla | 1232.90 |
| Zydus Lifesciences | 928.85 |
| Lupin | 2311.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: